These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 24312156)

  • 21. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.
    Anwaier G; Chen C; Cao Y; Qi R
    Int J Nanomedicine; 2017; 12():7681-7693. PubMed ID: 29089763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.
    Vigne J; Thackeray J; Essers J; Makowski M; Varasteh Z; Curaj A; Karlas A; Canet-Soulas E; Mulder W; Kiessling F; Schäfers M; Botnar R; Wildgruber M; Hyafil F;
    Mol Imaging Biol; 2018 Dec; 20(6):869-887. PubMed ID: 30250990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.
    Phinikaridou A; Andia ME; Shah AM; Botnar RM
    Am J Physiol Heart Circ Physiol; 2012 Dec; 303(12):H1397-410. PubMed ID: 23064836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
    Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M
    Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives.
    Wang X; Connolly TM
    Adv Clin Chem; 2010; 50():1-22. PubMed ID: 20521438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.
    Gargiulo S; Gramanzini M; Mancini M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
    Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
    Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
    Magnoni M; Ammirati E; Camici PG
    J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
    Mushenkova NV; Summerhill VI; Zhang D; Romanenko EB; Grechko AV; Orekhov AN
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tandem Stenosis to Induce Atherosclerotic Plaque Instability in the Mouse.
    Chen YC; Rivera J; Peter K
    Methods Mol Biol; 2015; 1339():333-8. PubMed ID: 26445800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive Molecular Imaging of Mouse Atherosclerosis.
    McAteer MA; Choudhury RP
    Methods Mol Biol; 2015; 1339():61-83. PubMed ID: 26445781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis: how far have we come?
    Kanwar RK; Chaudhary R; Tsuzuki T; Kanwar JR
    Nanomedicine (Lond); 2012 Jun; 7(6):899-916. PubMed ID: 22715913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast enhanced (DCE) magnetic resonance imaging (MRI) of atherosclerotic plaque angiogenesis.
    Calcagno C; Mani V; Ramachandran S; Fayad ZA
    Angiogenesis; 2010 Jun; 13(2):87-99. PubMed ID: 20526859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of sirtuins in attenuating plaque vulnerability in atherosclerosis.
    Velpuri P; Rai V; Agrawal DK
    Mol Cell Biochem; 2024 Jan; 479(1):51-62. PubMed ID: 36952068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 40. Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.
    Heo GS; Sultan D; Liu Y
    Q J Nucl Med Mol Imaging; 2020 Mar; 64(1):4-20. PubMed ID: 32077667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.